What Researchers Did
Researchers retrospectively analyzed a case series of 83 patients with complex regional pain syndrome (CRPS) treated with hyperbaric oxygen therapy (HBOT) over two years in Ostrava.
What They Found
Of 83 patients with CRPS treated with hyperbaric oxygen therapy (HBOT), 86% reported symptom relief at the end of treatment. Pain scores significantly decreased both at rest (from 3.2 to 1.6, p<0.001) and during activity (from 6.1 to 3.7, p<0.001), with 29% showing a large clinically significant response and 61% a partial response.
What This Means for Canadian Patients
Hyperbaric oxygen therapy may offer a new treatment option for Canadian patients suffering from complex regional pain syndrome, potentially reducing pain and improving limb function. Patients experiencing persistent CRPS symptoms could discuss the potential benefits and availability of HBOT with their healthcare providers.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in the Centre of Hyperbaric Medicine Ostrava.
Study Limitations
As a retrospective case series, this study lacks a control group and may be subject to selection bias, limiting the generalizability of its findings.